SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aayush Wellness touches the roof on launching Immunity Booster Tablets

09 Dec 2025 Evaluate

Aayush Wellness is currently trading at its upper circuit limit of Rs 32.23, up by 1.53 points or 4.98% from its previous closing of Rs 30.70 on the BSE.

The scrip opened at Rs 32.23 and has touched a high and low of Rs 32.23 and Rs 32.23 respectively. So far 118723 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs 267.30 on 18-Jul-2025 and a 52 week low of Rs 30.70 on 08-Dec-2025.

Last one week high and low of the scrip stood at Rs 32.23 and Rs 30.70 respectively. The current market cap of the company is Rs. 156.87 crore.

The Non-Institutions held 100.00% stake in the company.

Aayush Wellness has expanded its wellness portfolio with the launch of Immunity Booster Tablets, tapping into India’s rapidly growing $18 billion nutraceutical market. This strategic launch comes at a time when sedentary lifestyles, poor dietary choices, chronic stress, and seasonal changes have significantly weakened the immune resilience of millions. Designed to address this urgent need, the tablets offer a daily solution for strengthening the body's natural defense system in today’s fast-paced and health vulnerable environment.

In India, almost 38% of the population consumes an Unhealthy Diet, driven by urban lifestyles, lack of nutrition awareness, and economic constraints that make processed and high-calorie foods more accessible than minerals and nutrient-rich meals. Formulated with a potent blend of traditional and science-backed ingredients, Aayush Wellness’ Immunity Booster Tablets are designed to fortify the body’s natural defense system and promote daily resilience.

Aayush Wellness is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation.


Aayush Wellness Share Price

34.60 -0.80 (-2.26%)
16-Apr-2026 14:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1682.90
Dr. Reddys Lab 1223.90
Cipla 1231.45
Zydus Lifesciences 937.40
Lupin 2309.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×